Neuralink received a US FDA approval for the Blindsight chip in September 2024. It was designated as a ‘breakthrough device’.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback